Extensively drug-resistant tuberculosis; (XDR TB)

Back to Previous Page

- Add this to...
- Twitter
- Facebook
- Google Bookmarks
- LinkedIn

Extensively drug-resistant tuberculosis; (XDR TB)

Published Date:

February 2009

Series:

TB elimination

[PDF-326.24 KB]

Details:

Alternative Title:

XDR TB

Corporate Authors:

National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (U.S.), Division of Tuberculosis Elimination.

Description:

"Extensively drug-resistant tuberculosis (XDR TB) is a relatively rare type of multidrug-resistant tuberculosis (MDR TB). It is resistant to almost all drugs used to treat TB, including the two best first-line drugs: isoniazid and rifampin. XDR TB is also resistant to the best second-line medications: fluoroquinolones and at least one of three injectable drugs (i.e., amikacin, kanamycin, or capreomycin). (World Health Organization [WHO] definition for cases detected on initial susceptibility testing.)." - p. 1

Subject:

[+]

Document Type:

Pamphlet (or booklet)

Place as Subject:

United States

Collection(s):

Stephen B. Thacker CDC Library collection

Main Document Checksum:

[+]

Supporting Files:

No Additional Files

No Related Documents.

You May Also Like:

Increasing Drug Resistance in Extensively Drug-Resistant Tuberculosis, South Africa

Personal Author:

Shah, N. Sarita; Richardson, Jessica; Moodley, Prashini; Moodley, Salona; Babaria, Palav; Ramtahal, Melissa; Heysell, Scott K.; Li, Xuan; Moll, Anthony P.; Friedland, Gerald; Sturm, A. Willem; Gandhi, Neel R.;

Published Date:

Mar 2011

Source:

Emerg Infect Dis. 17(3):510-513.

Description:

We expanded second-line tuberculosis (TB) drug susceptibility testing for extensively drug-resistant Mycobacterium tuberculosis isolates from South Africa. Of 19 patients with extensively drug-resistant TB identified during February 2008-April 2009, ...

File Type:

[PDF - 169.61 KB]
Clonal Expansion of Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis, Japan

Personal Author:

Murase, Yoshiro; Maeda, Shinji; Yamada, Hiroyuki; Ohkado, Akihiro; Chikamatsu, Kinuyo; Mizuno, Kazue; Kato, Seiya; Mitarai, Satoshi;

Published Date:

Jun 2010

Source:

Emerg Infect Dis. 16(6):948-954.

Description:

The emergence and spread of multidrug-resistant (MDR) and extensively drug-resistant (XDR) tuberculosis (TB) has raised public health concern about global control of TB. To estimate the transmission dynamics of MDR and XDR TB, we conducted a DNA fing...

File Type:

[PDF - 154.44 KB]
Extensively Drug-Resistant Tuberculosis in Women, KwaZulu-Natal, South Africa

Personal Author:

O’Donnell, Max R.; Zelnick, Jennifer; Werner, Lise; Master, Iqbal; Loveday, Marian; Horsburgh, C. Robert; Padayatchi, Nesri;

Published Date:

Oct 2011

Source:

Emerg Infect Dis. 17(10):1942-1945.

Description:

To determine whether women in KwaZulu-Natal, South Africa, with drug-resistant tuberculosis (TB) were more likely than men to have extensively drug-resistant TB, we reviewed 4,514 adults admitted during 2003-2008 for drug-resistant TB. Female sex ind...

File Type:

[PDF - 185.41 KB]
Treatment Outcomes for Extensively Drug-Resistant Tuberculosis and HIV Co-infection

Personal Author:

O’Donnell, Max R.; Padayatchi, Nesri; Kvasnovsky, Charlotte; Werner, Lise; Master, Iqbal; Horsburgh, C. Robert;

Published Date:

Mar 2013

Source:

Emerg Infect Dis. 19(3):416-424.

Description:

High mortality rates have been reported for patients co-infected with extensively drug-resistant tuberculosis (XDR-TB) and HIV, but treatment outcomes have not been reported. We report treatment outcomes for adult XDR TB patients in KwaZulu-Natal Pro...

File Type:

[PDF - 477.02 KB]
Laboratory-based Surveillance of Extensively Drug-Resistant Tuberculosis, China

Personal Author:

Deng, Yunfeng; Wang, Yan; Wang, Junling; Jing, Hui; Yu, Chunbao; Wang, Haiying; Liu, Zhimin; Graviss, Edward A.; Ma, Xin;

Published Date:

Mar 2011

Source:

Emerg Infect Dis. 17(3):495-497.

Description:

To estimate the prevalence of extensively drug-resistant tuberculosis (XDR TB) in China, we retrospectively analyzed drug-resistance profiles of 989 clinical Mycobacterium tuberculosis isolates. We found 319 (32.3%) isolates resistant to ≥1 first-l...

File Type:

[PDF - 186.56 KB]